Preoperative assessment of liver function: A comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test

Liver International

Volumn 24, Issue 2, 2004, Pages 117-123

  Erdogan, Deha ^a   Heijnen, Bob H M ^a   Bennink, Roelof J ^a   Kok, Mariël ^a   Dinant, Sander ^a   Straatsburg, Irene H ^a   Gouma, Dirk J ^a   van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Hepatobiliary scintigraphy; Hepatocellular carcinoma; Indocyanine green clearance test; Klatskin tumours; Liver function; Non parenchymal tumours

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; INDOCYANINE GREEN; LACTATE DEHYDROGENASE; MEBROFENIN TC 99M; PROTHROMBIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOSARCOMA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATOBILIARY SCINTISCANNING; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KLATSKIN TUMOR; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER CLEARANCE; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE EVALUATION; PROTHROMBIN TIME;

EID: 2342531825     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.00901.x     Document Type: Article

References (34)

1. Detroz B, Sugarbaker P H, Kbol J A, et al. Causes of death in patients undergoing liver surgery. Cancer Treat Res 1994; 69: 241-57.
2. Capussotti L, Borgonovo G, Bouzari H, et al. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994; 81(3): 427-31.
3. Wu C C, Yeh D C, Lin M C, et al. Improving operative safety for cirrhotic liver resection. Br J Surg 2001; 88(2): 210-5.
4. Takano S, Oishi H, Kono S, et al. Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg 2000; 87(1): 65-70.
5. Lau H, Man K, Fan S T, et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84(9): 1255-9.
6. Watanabe Y, Kumon K. Assessment by pulse dye-densitometry indocyanine green (ICG) clearance test of hepatic function of patients before cardiac surgery: its value as a predictor of serious postoperative liver dysfunction. J Cardiothorac Vasc Anesth 1999; 13(3): 299-303.
7. Moody F G, Rikkers L F, Aldrete J S. Estimation of the functional reserve of human liver. Ann Surg 1974; 180(4): 592-8.
8. Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996; 24(5): 1165-71.
9. Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975; 105(17 Suppl.): 1-30.
10. Heyman S. Hepatobiliary scintigraphy as a liver function test. J Nucl Med 1994; 35(3): 436-7.
11. Engeler C M, Kuni C C, Nakhleh R, et al. Liver transplant rejection and cholestasis: comparison of technetium 99m-diisopropyl iminodiacetic acid hepatobiliary imaging with liver biopsy. Eur J Nucl Med 1992; 19(10): 865-70.
12. Meijer D K, Weert B, Vermeer G A. Pharmacokinetics of biliary excretion in man. VI. Indocyanine green. Eur J Clin Pharmacol 1988; 35(3): 295-303.
13. Trauner M, Meier P J, Boyer J L. Molecular pathogenesis of cholestasis. N Engl J Med 1998; 339(17): 1217-27.
14. Loberg M D, Cooper M, Harvey E, et al. Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J Nucl Med 1976; 17(7): 633-8.
15. Plevris J N, Jalan R, Bzeizi K I, et al. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 1999; 30(1): 142-8.
16. Ekman M, Fjalling M, Holmberg S, et al. IODIDA clearance rate: a method for measuring hepatocyte uptake function. Transplant Proc 1992; 24(1): 387-8.
17. Noguchi T, Imai T, Mizumoto R. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 1990; 37(2): 165-71.
18. Mitsumori A, Nagaya I, Kimoto S, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med 1998; 25(10): 1377-82.
19. Matsuzaki S, Onda M, Tajiri T, et al. Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology 1997; 25(4): 828-32.
20. Krishnamurthy G T, Turner F E. Pharmacokinetics and clinical application of technetium 99m-labeled hepatobiliary agents. Semin Nucl Med 1990; 20(2): 130-49.
21. Doo E, Krishnamurthy G T, Eklem M J, et al. Quantification of hepatobiliary function as an integral part of imaging with technetium-99m-mebrofenin in health and disease. J Nucl Med 1991; 32(1): 48-57.
22. Stremmel W, Berk P D. Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/ bilirubin binding protein. J Clin Invest 1986; 78(3): 822-6.
23. Goresky C A. Initial distribution and rate of uptake of sulphobromophthalein in the liver. Am J Physiol 1964; 207: 13-26.
24. Clements W D, Diamond T, McCrory D C, et al. Biliary drainage in obstructive jaundice: experimental and clinical aspects. Br J Surg 1993; 80(7): 834-42.
25. Schneider J F, Baker A L, Haines N W, et al. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology 1980; 79(6): 1145-50.
26. Imaeda T, Kanematsu M, Asada S, et al. Utility of Tc-99m GSA SPECT imaging in estimation of functional volume of liver segments in health and liver diseases. Clin Nucl Med 1995; 20(4): 322-8.
27. Sherman K E. Alanine aminotransferase in clinical practice. A review. Arch Intern Med 1991; 151(2): 260-5.
28. Alberts B, Bray D, Johnson A, Lewis J, Raff M, Roberts K, et al. Essential Cell Biology. New York and London: Garland Publishing, Inc., 1998.
29. Chijiiwa K, Watanabe M, Nakano K, et al. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice. Am J Surg 2000; 179(2): 161-6.
30. Brown P H, Juni J E, Lieberman D A, et al. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med 1988; 29(5): 623-30.
31. Knew M C. Tumors of the liver. In: Zakim D, Boyer T D, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: W.B.Saunders Company, 2002; 1513-48.
32. Bossuyt A, De Geeter F, Jacobs A, et al. Initial clinical experience with a new kit formulation of Tc-99m-β galactosylated albumin for functional hepatic imaging. Nucl Med Commun 1990; 11: 469-75.
33. Kim J S, Moon D H, Lee S G, et al. Hepatobiliary scintigraphy in the assessment of biliary obstruction after hepatic resection with biliary-enteric anastomosis. Eur J Nucl Med 2000; 27(2): 170-5.
34. Gupta S, Owshalimpur D, Cohen G, et al. Scintigraphic detection of segmental bile-duct obstruction. J Nucl Med 1982; 23(10): 890-1.